Neuroventis
Belgium BE-MF-000032626 Last updated 21 Oct 2026
Is this your brand? Sign in to claim this brand
- Devices
- 5
- Registries
- EUDAMEDGUDID
- FDA recalls
- 0
Catalogue
Neuroventis Platform 1.x.x Ref 1.x.x
Helpilepsy Dashboard Ref 2.X.X
MigraineManager Dashboard Ref 2.X.X
MigraineManager Application Ref 2.X.X
Helpilepsy Application Ref 2.X.X
About
Neuroventis emboldening people with neurological disorders. Learn how our technology is changing the world of neurological care.
What Neuroventis makes
Neuroventis makes software applications and dashboards for managing neurological conditions, including epilepsy and migraines. Their products include the Helpilepsy Dashboard and Application, as well as the MigraineManager Dashboard and Application. These are digital tools designed to support people with neurological disorders.
The company's portfolio is classified as Class I devices and is listed in the Eudamed registry. Neuroventis is based in Belgium. The devices are subject to regulatory oversight, with individual products authorized for use.
Frequently asked questions
What types of medical devices does Neuroventis develop?
Neuroventis develops software-based medical devices, specifically digital applications and dashboards that help manage neurological conditions such as epilepsy and migraines. This conclusion follows from the listed examples—Helpilepsy and MigraineManager dashboards and applications—which are described as tools for supporting people with these disorders.
Where is Neuroventis headquartered and which regulatory registry lists its devices?
Neuroventis is based in Belgium, as indicated by the country code BE in the data. Its devices are listed in the European Union's Eudamed registry, which is explicitly mentioned as the registry where the company's Class I devices are recorded.
How are Neuroventis' devices classified under EU medical device regulations?
All of Neuroventis' products are classified as Class I devices. This classification is directly stated in the device data, meaning they are considered low-risk medical devices and are subject to the corresponding regulatory requirements for that class.
Are Neuroventis' individual products approved or cleared for use?
The data notes that each product is individually authorized for use, which means that while the company itself is not approved, each specific software application or dashboard has undergone the necessary regulatory assessment to be permitted for clinical or consumer use.
Information
- Country
- Belgium
- Address
- 35A, Groeneweg, Overijse, Belgium
- Website
- neuroventis.care/
- [email protected]
- PRRC contact
- Ruth Beckers
- EUDAMED SRN
- BE-MF-000032626
- DUNS number
- 371379519